PreprintArticleVersion 1Preserved in Portico This version is not peer-reviewed
Impact of Varying Chest Wall Target Volume Delineation on Postmastectomy Radiation Therapy Outcomes in Breast Cancer Patients with Implant-Based Reconstruction
Hou, P.-Y.; Hsieh, C.-H.; Hsu, C.-X.; Kuo, D.-Y.; Lu, Y.-F.; Shueng, P.-W. Impact of Varying Chest Wall Target Volume Delineation on Postmastectomy Radiation Therapy Outcomes in Breast Cancer Patients with Implant-Based Reconstruction. J. Clin. Med.2023, 12, 6882.
Hou, P.-Y.; Hsieh, C.-H.; Hsu, C.-X.; Kuo, D.-Y.; Lu, Y.-F.; Shueng, P.-W. Impact of Varying Chest Wall Target Volume Delineation on Postmastectomy Radiation Therapy Outcomes in Breast Cancer Patients with Implant-Based Reconstruction. J. Clin. Med. 2023, 12, 6882.
Hou, P.-Y.; Hsieh, C.-H.; Hsu, C.-X.; Kuo, D.-Y.; Lu, Y.-F.; Shueng, P.-W. Impact of Varying Chest Wall Target Volume Delineation on Postmastectomy Radiation Therapy Outcomes in Breast Cancer Patients with Implant-Based Reconstruction. J. Clin. Med.2023, 12, 6882.
Hou, P.-Y.; Hsieh, C.-H.; Hsu, C.-X.; Kuo, D.-Y.; Lu, Y.-F.; Shueng, P.-W. Impact of Varying Chest Wall Target Volume Delineation on Postmastectomy Radiation Therapy Outcomes in Breast Cancer Patients with Implant-Based Reconstruction. J. Clin. Med. 2023, 12, 6882.
Abstract
Background: The target volume for post-mastectomy radiation therapy (PMRT) in breast cancer patients with reconstruction has been a subject of debate. This study aimed to assess the radiation dose distribution and treatment outcomes associated with different chest wall (CW) delineation according to ESTRO ACROP guideline for patients underwent implant-based reconstruction.
Methods: We conducted a retrospective review of breast cancer patients who underwent mastectomy followed by two-stage implant-based breast reconstruction and adjuvant radiation therapy (RT) between 2007 and 2022. The expanders/implants were positioned retropectorally. The chest wall target volumes were categorized into two groups: the prepectoral group, which excluded the deep lymphatic plexus, and the whole expander group.
Results: The study included 26 patients, 15 in prepectoral group and 11 in whole expander group. No significant differences were observed in normal organs exposure between the two groups. There was a trend toward a lower ipsilateral lung mean dose in the prepectoral group (10.2 vs. 11.1 Gy, p=0.06). Both groups exhibited limited instances of reconstruction failure and local recurrence.
Conclusions: For patients undergoing two-stage expander-implant retropectoral breast reconstruction and PMRT, our data have provided comparable outcomes and normal organs exposure for those omitting the deep lymphatic plexus.
Keywords
breast cancer; postmastectomy radiation therapy; implant-based reconstruction; target volume; dosimetry
Subject
Medicine and Pharmacology, Oncology and Oncogenics
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
